Research interest Development of health foods and new treatment strategies based on human diseased animal models. Current established human diseased animal models Including stroke, diabetes, hepatic cirrhosis, nonalcoholic fatty liver, atherosclerosis, obesity and tumor animal models. Publish Papers: Chen WY, Mao FC, Liu CH, Kuan YH, Lia NW, Wu CC, Chen CJ. Chromium supplementation improved post-stroke brain infarction and hyperglycemia. Metabolic Brain Disease 2016, 31:289-297. Chen TY, Wang MMC, Hsieh SK, Hsieh MH, Chen WY*, Tzen JTC. Pancreatic lipase inhibition of strictinin isolated from Pu’er tea (Cammelia sinensis) and its anti-obesity effects in C57BL6 mice. Journal of Functional Foods 2018, 48: 1-8. (*equal to corresponding author) Yang CP, Wang YY, Lin SY, Hong YJ, Liao KY, Hsieh SK, Pan PH, Chen CJ, Chen WY. Olanzapine induced dysmetabolic changes involving tissue chromium mobilization in female rats. Int J Mol Sci 2019, 20(3): E640. Patent: Mao FC, Chen WY. Composition for preventing and treating fatty liver. Number: US8,711,752B2.